407 related articles for article (PubMed ID: 17374746)
1. Differential inhibition of rat and human Na+-dependent taurocholate cotransporting polypeptide (NTCP/SLC10A1)by bosentan: a mechanism for species differences in hepatotoxicity.
Leslie EM; Watkins PB; Kim RB; Brouwer KL
J Pharmacol Exp Ther; 2007 Jun; 321(3):1170-8. PubMed ID: 17374746
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of bile acid transport across Na+/taurocholate cotransporting polypeptide (SLC10A1) and bile salt export pump (ABCB 11)-coexpressing LLC-PK1 cells by cholestasis-inducing drugs.
Mita S; Suzuki H; Akita H; Hayashi H; Onuki R; Hofmann AF; Sugiyama Y
Drug Metab Dispos; 2006 Sep; 34(9):1575-81. PubMed ID: 16760228
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the endothelin receptor antagonists ambrisentan, darusentan, bosentan, and sitaxsentan as substrates and inhibitors of hepatobiliary transporters in sandwich-cultured human hepatocytes.
Hartman JC; Brouwer K; Mandagere A; Melvin L; Gorczynski R
Can J Physiol Pharmacol; 2010 Jun; 88(6):682-91. PubMed ID: 20628435
[TBL] [Abstract][Full Text] [Related]
4. Interaction of fluvastatin with the liver-specific Na+ -dependent taurocholate cotransporting polypeptide (NTCP).
Greupink R; Dillen L; Monshouwer M; Huisman MT; Russel FG
Eur J Pharm Sci; 2011 Nov; 44(4):487-96. PubMed ID: 21945488
[TBL] [Abstract][Full Text] [Related]
5. Vectorial transport of bile salts across MDCK cells expressing both rat Na+-taurocholate cotransporting polypeptide and rat bile salt export pump.
Mita S; Suzuki H; Akita H; Stieger B; Meier PJ; Hofmann AF; Sugiyama Y
Am J Physiol Gastrointest Liver Physiol; 2005 Jan; 288(1):G159-67. PubMed ID: 15297262
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the endothelin receptor antagonists ambrisentan, bosentan, macitentan, and sitaxsentan as hepatobiliary transporter inhibitors and substrates in sandwich-cultured human hepatocytes.
Lepist EI; Gillies H; Smith W; Hao J; Hubert C; St Claire RL; Brouwer KR; Ray AS
PLoS One; 2014; 9(1):e87548. PubMed ID: 24498134
[TBL] [Abstract][Full Text] [Related]
7. Ritonavir, saquinavir, and efavirenz, but not nevirapine, inhibit bile acid transport in human and rat hepatocytes.
McRae MP; Lowe CM; Tian X; Bourdet DL; Ho RH; Leake BF; Kim RB; Brouwer KL; Kashuba AD
J Pharmacol Exp Ther; 2006 Sep; 318(3):1068-75. PubMed ID: 16720753
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the transport properties of organic anion transporting polypeptide 1 (oatp1) and Na(+)/taurocholate cotransporting polypeptide (Ntcp): comparative studies on the inhibitory effect of their possible substrates in hepatocytes and cDNA-transfected COS-7 cells.
Kouzuki H; Suzuki H; Stieger B; Meier PJ; Sugiyama Y
J Pharmacol Exp Ther; 2000 Feb; 292(2):505-11. PubMed ID: 10640286
[TBL] [Abstract][Full Text] [Related]
9. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation.
Stieger B
Handb Exp Pharmacol; 2011; (201):205-59. PubMed ID: 21103971
[TBL] [Abstract][Full Text] [Related]
10. Fasiglifam (TAK-875) Inhibits Hepatobiliary Transporters: A Possible Factor Contributing to Fasiglifam-Induced Liver Injury.
Li X; Zhong K; Guo Z; Zhong D; Chen X
Drug Metab Dispos; 2015 Nov; 43(11):1751-9. PubMed ID: 26276582
[TBL] [Abstract][Full Text] [Related]
11. Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics.
Ho RH; Tirona RG; Leake BF; Glaeser H; Lee W; Lemke CJ; Wang Y; Kim RB
Gastroenterology; 2006 May; 130(6):1793-806. PubMed ID: 16697742
[TBL] [Abstract][Full Text] [Related]
12. Electrophysiological characterization of human Na⁺/taurocholate cotransporting polypeptide (hNTCP) heterologously expressed in Xenopus laevis oocytes.
Masuda M; Ichikawa Y; Shimono K; Shimizu M; Tanaka Y; Nara T; Miyauchi S
Arch Biochem Biophys; 2014 Nov; 562():115-21. PubMed ID: 25168282
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.
Ni Y; Lempp FA; Mehrle S; Nkongolo S; Kaufman C; Fälth M; Stindt J; Königer C; Nassal M; Kubitz R; Sültmann H; Urban S
Gastroenterology; 2014 Apr; 146(4):1070-83. PubMed ID: 24361467
[TBL] [Abstract][Full Text] [Related]
14. Regulation of plasma membrane localization of the Na+-taurocholate cotransporting polypeptide (Ntcp) by hyperosmolarity and tauroursodeoxycholate.
Sommerfeld A; Mayer PG; Cantore M; Häussinger D
J Biol Chem; 2015 Oct; 290(40):24237-54. PubMed ID: 26306036
[TBL] [Abstract][Full Text] [Related]
15. Contribution of high basolateral bile salt efflux to the lack of hepatotoxicity in rat in response to drugs inducing cholestasis in human.
Jemnitz K; Veres Z; Vereczkey L
Toxicol Sci; 2010 May; 115(1):80-8. PubMed ID: 20147439
[TBL] [Abstract][Full Text] [Related]
16. Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na(+) -taurocholate cotransporting polypeptide knockout mice.
Slijepcevic D; Kaufman C; Wichers CG; Gilglioni EH; Lempp FA; Duijst S; de Waart DR; Elferink RP; Mier W; Stieger B; Beuers U; Urban S; van de Graaf SF
Hepatology; 2015 Jul; 62(1):207-19. PubMed ID: 25641256
[TBL] [Abstract][Full Text] [Related]
17. Na
Yu D; Zhang H; Lionarons DA; Boyer JL; Cai SY
Am J Physiol Regul Integr Comp Physiol; 2017 Apr; 312(4):R477-R484. PubMed ID: 28077388
[TBL] [Abstract][Full Text] [Related]
18. Xenobiotics inhibit hepatic uptake and biliary excretion of taurocholate in rat hepatocytes.
Kemp DC; Zamek-Gliszczynski MJ; Brouwer KL
Toxicol Sci; 2005 Feb; 83(2):207-14. PubMed ID: 15509663
[TBL] [Abstract][Full Text] [Related]
19. Contribution of sodium taurocholate co-transporting polypeptide to the uptake of its possible substrates into rat hepatocytes.
Kouzuki H; Suzuki H; Ito K; Ohashi R; Sugiyama Y
J Pharmacol Exp Ther; 1998 Aug; 286(2):1043-50. PubMed ID: 9694967
[TBL] [Abstract][Full Text] [Related]
20. The Lipid Raft Component Stomatin Interacts with the Na
Appelman MD; Robin MJD; Vogels EWM; Wolzak C; Vos WG; Vos HR; Van Es RM; Burgering BMT; Van de Graaf SFJ
Cells; 2020 Apr; 9(4):. PubMed ID: 32316189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
